Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured ...

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant ...

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant medications prescribed and ...

The pandemic expansion of Medicare telehealth will expire March 31 unless Congress acts to extend Medicare telehealth ...

Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...

More than 8 in 10 employers intend to offer employees and their dependents access to lower- or no-cost mental health support ...

Chronic Disease Flexible Coverage Act has passed the House of Representatives and will now go to the Senate. The bipar ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the U.S. Food and Drug Administration to take action against “bad actors” selling counterfeit weight loss drugs.